The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Resveratrol as an antioxidant and pro-oxidant agent: mechanisms and clinical implications
Abstract
Resveratrol (3,4′,5-trihydroxystilbene) is found in various plants, including grapes, berries and peanuts. It is also present in wines, especially red wines. During the last years, it has been the focus of numerous in vitro and in vivo studies investigating its biological attributes, which include mainly antioxidant and anti-inflammatory activities, anti-platelet aggregation effect, anti-atherogenic property, oestrogen-like growth-promoting effect, growth-inhibiting activity, immunomodulation and chemoprevention. In fact, recently, it has been demonstrated that the stilbene blocks the multistep process of carcinogenesis at various stages: tumour initiation, promotion and progression. More recent results provide interesting insights into the effect of this compound on the life span of yeasts and flies, implicating the potential of resveratrol as an anti-aging agent in treating age-related human diseases. Nevertheless, depending on the concentration of the phytoalexin and the cell type, it has also been shown that resveratrol can exhibit pro-oxidant properties, leading to oxidative breakage of cellular DNA in the presence of transition metal ions such as copper. Recently, it has been proposed that such a pro-oxidant action could be a common mechanism for anticancer and chemopreventive properties of plant polyphenols. The present paper is intended to provide the reader up-to-date information on the antioxidant and pro-oxidant properties of resveratrol and its clinical implications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Pharmacological preconditioning with resveratrol: role of nitric oxide
Hattori, R., Otani, H., Maulik, N., & Das, D. K. (2002) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01012.2001 · Cited by 202
RetractedCancer chemopreventive activity of resveratrol, a natural product derived from grapes
Jang, M., Cai, L., Udeani, G. O., Slowing, K. V., Thomas, C. F., Beecher, C. W. W., Fong, H. H. S., Farnsworth, N. R., Kinghorn, A. D., Mehta, R. G., et al. (1997) · Science · doi:10.1126/science.275.5297.218 · Cited by 4,935
Wine, alcohol, platelets, and the French paradox for coronary heart disease
Renaud, S., & de Lorgeril, M. (1992) · The Lancet · doi:10.1016/0140-6736(92)91277-f · Cited by 3,643
Resveratrol as an anti-inflammatory and anti-aging agent: Mechanisms and clinical implications
Alarcón de la Lastra, C., & Villegas, I. (2005) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200500022 · Cited by 703
Self-citationWine as a biological fluid: History, production, and role in disease prevention
Soleas, G. J., Diamandis, E. P., & Goldberg, D. M. (1997) · Journal of Clinical Laboratory Analysis · doi:10.1002/(sici)1098-2825(1997)11:5<287::aid-jcla6>3.0.co;2-4 · Cited by 687
Resveratrol scavenges reactive oxygen species and effects radical-induced cellular responses
Leonard, S. S., Xia, C., Jiang, B.-H., Stinefelt, B., Klandorf, H., Harris, G. K., & Shi, X. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.08.105 · Cited by 681
Cardioprotective effect of resveratrol, a natural antioxidant derived from grapes
Hung, L. (2000) · Cardiovascular Research · doi:10.1016/s0008-6363(00)00102-4 · Cited by 541
Resveratrol: from grapevines to mammalian biology
Pervaiz, S. (2003) · The FASEB Journal · doi:10.1096/fj.03-0168rev · Cited by 520
Tsai, S., Lin‐Shiau, S., & Lin, J. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702357 · Cited by 511
Martinez, J., & Moreno, J. J. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00380-9 · Cited by 408
A reappraisal of the potential chemopreventive and chemotherapeutic properties of resveratrol
Gusman, J. (2001) · Carcinogenesis · doi:10.1093/carcin/22.8.1111 · Cited by 388
Wadsworth, T. L., & Koop, D. R. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00002-7 · Cited by 302
Lorenz, P., Roychowdhury, S., Engelmann, M., Wolf, G., & Horn, T. F. W. (2003) · Nitric Oxide · doi:10.1016/j.niox.2003.09.005 · Cited by 297
Resveratrol: Preventing properties against vascular alterations and ageing
Delmas, D., Jannin, B., & Latruffe, N. (2005) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200400098 · Cited by 269
Martı&#x;n, A. R., Villegas, I., La Casa, C., & de la Lastra, C. A. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2003.12.024 · Cited by 258
Self-citationOrallo, F., Álvarez, E., Camiña, M., Leiro, J. M., Gómez, E., & Fernández, P. (2002) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12861-1 · Cited by 250
Martín, A. R., Villegas, I., Sánchez‐Hidalgo, M., & De La Lastra, C. A. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706469 · Cited by 228
Self-citationAzmi, A. S., Bhat, S. H., Hanif, S., & Hadi, S. M. (2006) · FEBS Letters · doi:10.1016/j.febslet.2005.12.059 · Cited by 190
Potential Mechanism by Which Resveratrol, a Red Wine Constituent, Protects Neurons
ZHUANG, H., KIM, Y., KOEHLER, R. C., & DORÉ, S. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb07534.x · Cited by 186
Resveratrol modulation of signal transduction in apoptosis and cell survival: A mini-review
Fulda, S., & Debatin, K. (2006) · Cancer Detection and Prevention · doi:10.1016/j.cdp.2006.03.007 · Cited by 158
Zheng, L.-F., Wei, Q.-Y., Cai, Y.-J., Fang, J.-G., Zhou, B., Yang, L., & Liu, Z.-L. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2006.09.007 · Cited by 153
Resveratrol and Cancer: Chemoprevention, Apoptosis, and Chemoimmunosensitizing Activities
Cal, C., Garbán, H., Jazirehi, A. R., Yeh, C.-H., Mizutani, Y., & Bonavida, B. (2003) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1568011033353443 · Cited by 152
Mayo, J. C., Tan, D. X., Sainz, R. M., Natarajan, M., López‐Burillo, S., & Reiter, R. J. (2003) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(02)00527-5 · Cited by 151
Azmi, A. S., Bhat, S. H., & Hadi, S. M. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.04.077 · Cited by 141
Matsuda, H., Kageura, T., Morikawa, T., et al. (2000) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(99)00702-7 · Cited by 140
Resveratrol as a new type of DNA-cleaving agent
Fukuhara, K., & Miyata, N. (1998) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(98)00585-x · Cited by 139
Yen, G., Duh, P., & Lin, C.-W. (2003) · Free Radical Research · doi:10.1080/1071576031000083099 · Cited by 130
Effects of metal chelating agents on the oxidation of lipids induced by copper and iron
Yoshida, Y., Furuta, S., & Niki, E. (1993) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(93)90052-b · Cited by 124
Ozgová, Š., Heřmánek, J., & Gut, I. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(03)00425-8 · Cited by 120
Prooxidant activity of resveratrol in the presence of copper ions: Mutagenicity in plasmid DNA
Ahmad, A., Syed, F. A., Singh, S. P., & Hadi, S. M. (2005) · Toxicology Letters · doi:10.1016/j.toxlet.2005.04.001 · Cited by 99
Pro‐oxidant Activity of Low Doses of Resveratrol Inhibits Hydrogen Peroxide—Induced Apoptosis
Ahmad, K. A., Clement, M., & Pervaiz, S. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1299.067 · Cited by 95
Resveratrol modulates apoptosis and oxidation in human blood mononuclear cells
Losa, G. A. (2003) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2003.01219.x · Cited by 90
Resveratrol in cell fate decisions
Holme, A. L., & Pervaiz, S. (2007) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-006-9053-y · Cited by 78
Soleas, G. J., Yan, J., & Goldberg, D. M. (2001) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(01)35238-2 · Cited by 66
The basis for the chemopreventive action of resveratrol
Roemer, K., & Mahyar-Roemer, M. (2002) · Drugs of today · doi:10.1358/dot.2002.38.8.820097 · Cited by 61
Resveratrol modulates rat macrophage functions
Leiro, J. M., Álvarez, E., García, D., & Orallo, F. (2002) · International Immunopharmacology · doi:10.1016/s1567-5769(02)00014-0 · Cited by 48
Reactive Oxygen Species Drives Myocardial Angiogenesis?
Maulik, N. (2006) · Antioxidants and Redox Signaling · doi:10.1089/ars.2006.8.2161 · Cited by 39
Cited by
Oxidative Stress, Prooxidants, and Antioxidants: The Interplay
Rahal, A., Kumar, A., Singh, V., Yadav, B., Tiwari, R., Chakraborty, S., & Dhama, K. (2014) · BioMed Research International · doi:10.1155/2014/761264 · Cited by 1,706
Resveratrol: A Double-Edged Sword in Health Benefits
Salehi, B., Mishra, A. P., Nigam, M., Sener, B., Kilic, M., Sharifi-Rad, M., Fokou, P. V. T., Martins, N., & Sharifi-Rad, J. (2018) · Biomedicines · doi:10.3390/biomedicines6030091 · Cited by 1,129
Natural products to drugs: natural product-derived compounds in clinical trials
Butler, M. S. (2008) · Natural Product Reports · doi:10.1039/b514294f · Cited by 1,075
Natural products: An evolving role in future drug discovery
Mishra, B. B., & Tiwari, V. K. (2011) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2011.07.057 · Cited by 860
Potential Adverse Effects of Resveratrol: A Literature Review
Shaito, A., Posadino, A. M., Younes, N., Hasan, H., Halabi, S., Alhababi, D., Al-Mohannadi, A., Abdel-Rahman, W. M., Eid, A. H., Nasrallah, G. K., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21062084 · Cited by 716
Metadata
- Authors
- de la Lastra, C. A., & Villegas, I.
- Venue
- Biochemical Society Transactions
- Publisher
- Portland Press Ltd.
- Published
- 2007-10-25
- Volume
- 35
- Issue
- 5
- Pages
- 1156-1160
- ISSN
- 0300-5127 (ISSN-L)
- 1470-8752
- OpenAlex
- W187782327
- Cited by
- 740
- References
- 37
- FWCI
- 10.10
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.